Stock A005690 PHARMICELL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Pharmicell Co., Ltd.

Equities

A005690

KR7005690003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
5,560 KRW -0.54% Intraday chart for Pharmicell Co., Ltd. -2.80% -8.40%
2021 Pharmicell Co., Ltd. announced that it has received KRW 22 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., Investment Arm CI
2021 Pharmicell Co., Ltd. announced that it expects to receive KRW 22 billion in funding from Samsung Securities Co. Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., Investment Arm and other investors CI

Business Summary

Pharmicell Co., Ltd. is a Korea-based company principally engaged in the biopharmaceutical business. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. It also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides women’s and men’s apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Biochemistry Division
97.0 %
58,695 97.5 % 54,566 97.0 % -7.03%
Biomedical Division
3.0 %
1,487 2.5 % 1,661 3.0 % +11.73%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
58.6 %
34,411 57.2 % 32,966 58.6 % -4.20%
United States
21.5 %
15,585 25.9 % 12,068 21.5 % -22.57%
Europe
13.0 %
5,248 8.7 % 7,338 13.0 % +39.83%
Asia
6.9 %
4,939 8.2 % 3,856 6.9 % -21.93%

Managers

Managers TitleAgeSince
Hyun-Soo Kim CEO
 Chief Executive Officer 60 18/08/09
Kwang-Rae Kim SAM
 Sales & Marketing 54 -

Members of the board

Members of the board TitleAgeSince
Byung-Moo Yoo BRD
 Director/Board Member 60 11/08/11
Hyun-Soo Kim CEO
 Chief Executive Officer 60 18/08/09
Sung-Nyun Kim BRD
 Director/Board Member 56 -
Tae-Se Kwon BRD
 Director/Board Member 69 -
Gil-Soo Jung BRD
 Director/Board Member 48 07/02/21
Seung-Gyung Han BRD
 Director/Board Member 69 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 60,016,964 54,174,022 ( 90.26 %) 12,950 ( 0.0216 %) 90.26 %

Shareholders

NameEquities%Valuation
Hyun-Soo Kim
10.89 %
6,535,247 10.89 % 28 M ₩
National Pension Service of Korea
4.061 %
2,437,429 4.061 % 10 M ₩
Hee-seung Hong
0.3775 %
226,539 0.3775 % 965 425 ₩
Pharmicell Co., Ltd. Employee Stock Ownership Association
0.3089 %
185,418 0.3089 % 790 183 ₩
KB Asset Management Co. Ltd.
0.0393 %
23,596 0.0393 % 100 557 ₩
PHARMICELL CO., LTD.
0.0216 %
12,950 0.0216 % 55 188 ₩
DFA Australia Ltd.
0.008668 %
5,202 0.008668 % 22 169 ₩
Dimensional Fund Advisors Ltd.
0.007868 %
4,722 0.007868 % 20 123 ₩
Mirae Asset Global Investments Co., Ltd.
0.000793 %
476 0.000793 % 2 029 ₩
Hak Sun Jang
0.000133 %
80 0.000133 % 341 ₩

Holdings

NameEquities%Valuation
PHARMICELL CO., LTD.
0.02%
 12,950 0.02% 55,188 $

Company contact information

Pharmicell Co., Ltd.

7/F, Sang-Bong Building 874 Eonju-ro

06017, Seoul

+

http://www.pharmicell.com
address Pharmicell Co., Ltd.(A005690)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
PHARMICELL CO., LTD. Stock Pharmicell Co., Ltd.
-8.40% 247M
CSL LIMITED Stock CSL Limited
-2.32% 90.45B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.68% 41.45B
BIOGEN INC. Stock Biogen Inc.
-10.90% 33.57B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-19.56% 14.73B
INCYTE CORPORATION Stock Incyte Corporation
-9.06% 12.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.34% 11.7B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.53% 11.44B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+3.75% 8.79B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.32% 8.35B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A005690 Stock
  4. Company Pharmicell Co., Ltd.